Diabetes mellitus in early pregnancy increases the risk in infants of birth defects, such as neural tube defects (NTDs), known as diabetic embryopathy. NTDs are associated with hyperglycemia-induced protein misfolding and Caspase-8-induced programmed cell death. The present study shows that misfolded proteins are ubiquitinylated, suggesting that ubiquitin-proteasomal degradation is impaired. Misfolded proteins form aggregates containing ubiquitin-binding protein p62, suggesting that autophagic-lysosomal clearance is insufficient. Additionally, these aggregates contain the neurodegenerative disease-associated proteins α-Synuclein, Parkin, and Huntingtin (Htt). Aggregation of Htt may lead to formation of a death-inducing signaling complex of Hip1, Hippi, and Caspase-8. Treatment with chemical chaperones, such as sodium 4-phenylbutyrate (PBA), reduces protein aggregation in neural stem cells in vitro and in embryos in vivo. Furthermore, treatment with PBA in vivo decreases NTD rate in the embryos of diabetic mice, as well as Caspase-8 activation and cell death. Enhancing protein folding could be a potential interventional approach to preventing embryonic malformations in diabetic pregnancies.
diabetic embryopathy | protein folding | protein aggregation | Caspase-8 | chemical chaperone P regnancies complicated by diabetes mellitus have a higher risk of resulting in infants with congenital birth defects, a complication known as diabetic embryopathy (1) . The defects in the central nervous system are the result of perturbed neural tube formation (neurulation) during early embryogenesis and are thus referred to as neural tube defects (NTDs) (2) . Neurulation is a process that begins with development of the neural folds at about week 2 of gestation in humans and embryonic day 8 (E8) in the mouse, and concludes with fusion of the neural tissues at the dorsal midline, to form the neural tube, by about week 4 in humans and E11.5 in the mouse (3, 4) . The failure of neural tube closure in diabetic embryopathy is associated with excessive programmed cell death (apoptosis) in the neural epithelium (1) . Diabetes-induced apoptosis is mediated by Caspase-8 (5), which is activated by a death-inducing signaling complex (DISC) (6, 7) .
Maternal hyperglycemia, the major teratogen of diabetesinduced embryonic malformations, exerts profound effects on intracellular metabolic homeostasis and organelle function (1) . Perturbation of rough endoplasmic reticulum (ER) function has been implicated in diabetic embryopathy by the observations that factors involved in the unfolded protein response are up-regulated (8, 9) , due to accumulation of improperly folded proteins in the ER lumen (10) . Misfolded proteins are usually degraded through the ubiquitin-proteasome system (UPS), including the ER-associated protein degradation pathway (11) (12) (13) . However, if the UPS is impaired, misfolded proteins escape degradation and are released into the cytosol (14) . Accumulation of misfolded cytotoxic proteins within a cell perturbs organelle functions, such as inducing the mitochondria to generate an abundance of reactive oxygen species (ROS), which results in oxidative stress (15, 16) and disrupts intracellular signaling, thus altering cellular activities (17) .
Misfolded proteins are prone to forming aggregates that are resistant to UPS degradation (18) . Aggregation of α-Synuclein (α-Syn), Parkin, and Huntingtin (Htt) has been found to be involved in the pathogenesis of Alzheimer's, Parkinson's, and Huntington's diseases (19) (20) (21) (22) . Protein aggregates can be eliminated by the autophagic-lysosomal system (ALS) (23, 24) . The transfer of ubiquitinylated proteins to the ALS is mediated by a ubiquitin-binding protein, p62, also known as Sequestosome-1 (25, 26) . Protein aggregates containing p62 are commonly seen in neurodegenerative diseases, indicating deficiency of the ALS in the pathogenesis of these diseases (27) . These neural degenerative disease-associated proteins are expressed in the developing neural tube (28) (29) (30) ; however, it is unknown whether they are involved in hyperglycemia-induced NTDs.
In the present study, we aimed to investigate the fate of these misfolded proteins and their potential effects on apoptotic regulation and NTD formation. We also explored an approach to alleviate protein aggregation by enhancing protein folding using chemical chaperones to provide insights into the mechanisms of diabetic embryopathy, and to help identify potential strategies to prevent diabetes-induced birth defects.
Results
Protein Ubiquitinylation and Aggregation. Misfolded proteins are usually ubiquitinylated and degraded by the UPS (13) . However, when the UPS is impaired, ubiquitinylated proteins can accumulate in the cell. Because we hypothesized that UPS dysfunction
Significance
Neural tube defects in infants of women with diabetes are associated with disrupted protein folding and increased programmed cell death in embryonic cells. Misfolded proteins are ubiquitinylated and form aggregates that contain the neurodegenerative disease-associated proteins α-Synuclein, Parkin, and Huntingtin (Htt). Aggregation of Htt leads to formation of a Hip1-Hippi-Caspase-8 complex to activate Caspase-8. Treatment with chemical chaperones alleviates protein aggregation and decreases neural tube defects in the embryos of diabetic mice. Targeting misfolded proteins could be a potential approach to preventing birth defects in diabetic pregnancies.
plays a role in diabetes-induced NTDs, we generated diabetic pregnant mice (10 wk old) and collected neural tissues of embryos at E9.5, an important stage in murine neurulation (3, 4) , to quantify changes in levels of ubiquitinylated proteins. In the dorsal brain regions (SI Appendix, Fig. S1 ), where cranial NTDs occur, the levels of global protein ubiquitinylation were significantly higher in the diabetes mellitus (DM) group, compared with the nondiabetic (ND) group ( Fig. 1 A and B) .
Accumulation of misfolded proteins has been implicated in diabetic embryopathy (8, 9) , but the fate of these misfolded proteins, which can aggregate and become cytotoxic (18) , has not been previously explored. We used a Proteostat system to examine protein aggregates in the neural tube of embryos at E9.5 and E10.5. Proteostat is a rotor molecule that emits fluorescence when it binds to the tertiary structure of aggregated proteins. It has been validated to specifically detect protein aggregates and aggresomelike inclusion bodies in cells and cell lysates (31) .
In the tissue sections of the dorsal brain (SI Appendix, Fig. S1 ), more intense Proteostat signals were observed in the DM group than in the ND group ( Fig. 1 C and F) . Quantification of the levels of protein aggregation showed significant increases in the DM group, compared with those in the ND group (Fig. 1I) .
Aggregates of ubiquitinylated proteins are subject to ALS clearance, mediated by ubiquitin-binding protein p62 (25, 26) . Doublelabeling with Proteostat to detect protein aggregates and an antibody to detect p62 revealed colocalization of protein aggregates and p62 ( Fig. 1 F-H) .
To determine whether high glucose induces the protein aggregation observed in embryos of diabetic dams, we used neural stem cells, derived from E9 mouse neural tubes, as a model system (32) . The cells were cultured in a concentration of 27.8 mM (500 mg/dL) glucose [high glucose (HG)] or 6 mM (100 mg/dL) glucose [normal glucose (NG)] and assessed for protein aggregation. Significant increases in protein aggregation and colocalization with p62 were observed in the cells of the HG group, compared with those in the cells of the NG group ( Fig. 1 J- 
P).
Aggregation of Neurodegenerative Disease-Associated Proteins.
Aggregation of α-Syn, Parkin, and Htt is seen in Alzheimer's, Parkinson's, and Huntington's diseases (19) . Because these proteins are also expressed in the neural epithelium of the developing embryo (SI Appendix, Fig. S2 ) (28) (29) (30) , we sought to determine whether these neurodegenerative disease-associated proteins also aggregate in the neural tube of embryos from diabetic mice.
We used a proximity ligation assay (PLA) to examine interactions between p62 and α-Syn, Parkin, and Htt in situ on tissue sections. When two proteins physically interact, the antibodies that recognize them are in a close proximity so that conjugated oligonucleotides can serve as guides to ligate additional oligonucleotides to form a circular template for DNA synthesis. The DNA amplified from the template is then detected using a fluorescent dye-labeled probe (33) .
PLA signals in the dorsal region of the neural tube at E9.5 in the DM group were significantly higher than those in the ND group ( Fig. 2 A-I), as well as in the neural stem cells cultured in high glucose (SI Appendix, Fig. S3 ). Such protein-protein interactions were also detected in high glucose-treated neural stem cells, using a coimmunoprecipitation assay ( Fig. 2 J and K).
Formation of Death-Inducing Signaling Complex. High levels of apoptosis in NTDs in diabetic embryopathy are mediated by Caspase-8 (34) . Caspase-8 can be activated by a DISC. One such DISC contains Htt-interacting protein 1 (Hip1) and Hip1 protein interactor (Hippi), which forms when Htt aggregates to release Hip1 (35, 36) . We investigated if Hip1, Hippi, and Caspase-8 form this unique DISC in embryos from diabetic dams. Interactions between these proteins were detected, using PLA, in the dorsal region of the neural tube in E9.5 embryos. The levels of these protein complexes were significantly higher in the DM group than in the ND group (Fig. 3) .
Effects of Chemical Chaperones on Protein Aggregation in Vitro and
in Vivo. To examine if protein aggregation in diabetic embryopathy is the result of aberrant protein folding, we treated embryonic neural stem cells with chemical chaperones, including sodium 4-phenylbutyrate (PBA), sodium taurochenodeoxycholate (TUDCA), and trimethylamine N-oxide (TMAO). The treatments significantly decreased protein aggregation in neural stem cells cultured in high glucose (HG+PBA: 25 μM and 50 μM; HG+TUDCA: 25 μM and 50 μM; HG+TMAO: 100 μM and 250 μM), compared with the HG+VEH group (Fig. 4 A-C) .
To investigate whether chemical chaperones can alleviate the hyperglycemia-induced protein-folding crisis, and can reduce diabetes-induced embryonic malformations in vivo, we used PBA to treat diabetic pregnant mice (100 mg/kg, daily) from E6.5 to E9.5, the period of early neurulation. After treatment, neural tissues were collected at E9.5 and E10.5 for examination of protein modification and aggregation. In the embryos of the DM+PBA group, the levels of global protein ubiquitinylation and aggregation were significantly decreased, compared with those in the DM+VEH group (Fig. 4 D and E) . The involvement of α-Syn, Parkin, and Htt in the p62-containing inclusion bodies was also significantly decreased, compared with that in the DM+VEH group (Fig. 4 F-H) .
Effects of PBA on NTDs, Apoptosis, and Caspase-8 Activation. In human diabetic pregnancies, NTDs in offspring are present in the brain and spinal cord, and are frequently manifested as exencephaly, anencephaly, and spina bifida (37). Our mouse model system recapitulates these anomalies. Embryos from the DM+VEH group displayed NTDs in the forebrain (presumptive anencephaly), midbrain and/or hindbrain (presumptive exencephaly), and spinal cord (spina bifida) (Fig. 5B) (38) . The NTD rate, examined at E10.5, in the DM+VEH group was significantly higher than that in the ND group (Table 1) . When diabetic pregnant mice were treated with PBA, the NTD rate was significantly lower than that in the DM+VEH group, but similar to that in the ND group (Table 1 and Fig. 5 A-C) . PBA treatment also significantly reduced the levels of apoptosis in the dorsal region of the neural tube at E9.5 and E10.5 (Fig. 5 D-F) and also reduced the levels of Caspase-8 activation (Fig. 5 G and H) .
Effects of PBA on Cellular Stress and Cell Survival Signaling. It was previously shown that maternal diabetes exacerbates ER stress, indicated by an increased expression of activating transcription factor 6 (Atf6), phosphorylated (p) protein kinase RNA-like ER kinase (PERK), and α-subunit of eukaryotic initiation factor 2 (p-eIF2α). Maternal diabetes also compromises cell survival regulation, indicated by decreased expression of protein kinase Bα (p-Pkbα) and mechanistic target of rapamycin (p-mTOR) (8, 15) . In the present study, PBA treatment significantly decreased the levels of Atf6 (Fig. 6A) , p-Perk (Fig. 6B) , and p-eIF2α (Fig.  6C ) and increased the activation of p-Pkbα (Fig. 6D ) and p-mTOR (Fig. 6E) , compared with the levels of the proteins in the DM+VEH group, at E9.5 and E10.5.
Discussion
Maternal diabetes mellitus perturbs protein folding in cells of the embryo, leading to accumulation of improperly folded proteins (8, 9) . However, the fate of these abnormally folded proteins, which likely interfere with normal intracellular signaling and cellular activities, has not been explored. Here, we show that misfolded proteins form aggregates and are resistant to degradation via the UPS and ALS. In addition, the protein aggregates contain α-Syn, Parkin, and Htt, which are also involved in the pathogenesis of neurodegenerative diseases, including Alzheimer's, Parkinson's, and Huntington's diseases (19) (20) (21) (22) . The presence of these aggregates in maternal diabetes-induced embryonic NTDs suggests that similar molecular processes may be occurring in diabetic embryopathy and neurodegenerative diseases.
To control the quality of proteins, abnormally folded proteins are usually flagged with ubiquitin and degraded by the UPS (12) . In the neural tube of embryos of diabetic mice, global protein ubiquitinylation is increased, indicating a significant accumulation of misfolded proteins. Abnormally folded proteins can aggregate and form inclusion bodies in the cell, thereby perturbing intracellular signaling and cell activity. Although these aggregates can be eliminated by p62-mediated ALS (25, 26) , the accumulation of p62-containing aggregates indicates an impairment of the ALS in embryonic cells of diabetic mice. Three proteins associated with neurodegenerative diseases, α-Syn, Parkin, and Htt, also form aggregates in the embryos of diabetic mice. These proteins are expressed in the neural epithelium during neurulation (28) (29) (30) . Aggregation of these proteins may abolish their normal functions and also disturb intracellular signaling, as seen in neurodegenerative diseases (19) (20) (21) (22) .
Protein aggregates containing α-Syn, known as Lewy bodies (LBs), are seen in many diseases, including neurodegenerative diseases, dementia with LBs, and multiple system atrophy, and thus are referred to as syncleinopathies (39, 40) . The role of α-Syn inclusion bodies in the pathogenesis of neurodegenerative diseases is not completely understood; however, α-Syn interacts with phospholipids on plasma membranes and may be involved in altered phospholipid metabolism (41) . Aberrant phospholipid metabolism has also been suggested as an important process in diabetic embryopathy (15) . α-Syn is involved in regulation of mitochondrial dynamics, such as fusion and fission (42) , and LBs localized in the mitochondria can influence electron transport to generate ROS (43, 44) . Both perturbed mitochondrial dynamics and ROS overproduction are associated with hyperglycemia-induced embryonic malformations in diabetic embryopathy (1, 15) ; therefore, the role of LBs in diabetic embryopathy deserves further investigation.
Parkin is an E3 ubiquitin ligase, which plays a role in protein degradation via the UPS (45, 46) . Mutations in the PARK2 gene cause PARKIN aggregation and loss of function in neurons, which are hallmarks of Parkinson's disease (47) . In the present study, we observed Parkin aggregation in the neural cells of embryos from diabetic dams, suggesting that an impaired Parkin-mediated UPS may be involved in diabetic embryopathy. PARKIN interacts with PTEN-induced putative kinase 1 (PINK1) on the mitochondrial membrane (48, 49) . The action of the PARKIN-PINK1 complex is to regulate mitochondrial morphogenesis and remove damaged mitochondria through a form of ALS (50, 51) . Mutations in PINK1 are associated with mitochondrial dysmorphogenesis and dysfunction, which are also characteristics of Parkinson's disease (52, 53) . In diabetic embryopathy, the aggregation of Parkin may perturb mitochondrial dynamics and protein quality control, thereby leading to embryonic malformations (15) .
Htt aggregation causes neuronal death via multiple mechanisms, including activating Caspase-8 (54). Caspase-8-dependent apoptosis has been observed in diabetes-induced NTDs (5). The DISC, which activates Caspase-8 in the tumor necrosis factor receptor (TNFR) and Fas receptor signaling systems, consists of Fasassociated death domain-containing protein, TNFR-associated factor 2, and TNFR-associated death domain protein (6, 7). However, in Huntington's disease, Caspase-8 can be activated by a unique DISC, consisting of HIP1 and HIPPI (55) . HTT aggregation releases HIP1 from the cell membrane to make it available for DISC formation (36) . In this study, we observed that Hip1, Hippi, and Caspase-8 form a complex in the neural tissues of embryos from diabetic dams, suggesting that Htt aggregation serves as one mechanism of Caspase-8 activation in diabetic embryopathy.
The pathway that begins with disrupted protein folding and ends with protein aggregation in embryonic cells subjected to (56) and is used to ameliorate protein folding-associated diseases (57). These observations suggest that targeting the protein-folding crisis is a potential interventional approach to prevent diabetes-associated birth defects. Previous efforts to reduce embryonic malformations in diabetic embryopathy have focused on amelioration of oxidative stress using antioxidants (1) . However, the effectiveness of antioxidants in humans remains questionable, as multiple large-scale human trials that have used antioxidants (i.e., vitamin C and vitamin E) to treat other diseases (i.e., preeclampsia, cardiovascular disease) have revealed unsatisfactory results (58) (59) (60) . Although the reasons for this failure have not been identified, it is speculated that other cellular stress conditions (i.e., ER stress), which may not be affected by antioxidant therapies, may be involved (60) . Chemical chaperones have been shown to improve diabetes in animal models by restoring protein folding, thereby reducing cellular stress (61, 62) . Chemical chaperones have also been tested in humans to treat protein-folding-related diseases (57, 63, 64) . The observation that PBA reduces embryonic malformations in diabetic mice suggests that targeting aberrant protein folding could be a means to prevent birth defects in diabetic pregnancies.
In addition to enhancing protein folding, targeting protein aggregation could mitigate the cytotoxicity of protein inclusion bodies (65) . For example, efforts have been taken to block or disrupt α-Syn oligomization in Parkinson's disease with promising outcomes (66) . The delineation of the protein-folding crisis and aggregation in hyperglycemia-induced embryonic malformations provides opportunities for developing interventions at multiple levels to prevent birth defects in diabetic pregnancies. (A-C) ER stress factors Atf6 (*P = 0.045, n = 3 embryos), p-Perk (*P = 0.04, n = 3 embryos), and p-eIF2α (*P = 0.042, n = 5 embryos). (D and E) Cell survival factors p-Pkbα (*P = 0.0013, n = 4 embryos) and p-mTOR (*P = 0.032, n = 4 embryos). β-Actin, loading control; DM, diabetes mellitus; ND, nondiabetic; PBA, phenylbutyrate; VEH, vehicle. 
Materials and Methods
Diabetes mellitus was induced in female mice (C57BL/6J) by i.v. injection of streptozotocin. The use of animals was approved by the Institutional Animal Care and Use Committee of University of Maryland, Baltimore. Detailed procedures about the generation of diabetic mice, cell culture, protein aggregation assay, TUNEL, proximity ligation assay, coimmunoprecipitation, and Western blot assay, as well as statistical analyses, can be found in the SI Appendix, Supplementary Materials and Methods.
